Mode of Presentation and Associated Autoimmune Diseases in Children with Autoimmune Hepatitis

Yıl 2022, , 95 - 101, 28.02.2022

Nelgin Gerenli , Coşkun Çeltik

https://doi.org/10.54005/geneltip.1037269

Cited By: 1

Öz

Background and Aims: Autoimmune hepatiti (AIH) is an inflammatory disease of the liver with variable clinical presentations. 20-40% of the patients with AIH had another associated autoimmune or autoinflammatory disease. This study aimed to assess mode of presentation, biochemical features and outcomes in children with AIH, as well as to evaluate the frequency of concomitant autoimmune diseases (CAIDs).
Materials and Methods: 17 children, aged 6 to 18 years were enrolled. The mode of presentation and accompanying autoimmune diseases were recorded. Biochemical parameters as well as immunoglobulin G levels were evaluated either at time of submission and thereafter.
Results: Fourteen patients had type-1AIH (10 females, 4 males), and three (2 males, 1 female) had type-2AIH. The mode of presentation was acute in 53% and incidental enzyme elevation in 47% of them. There was an associated autoimmune or auto-inflammatory disease in 35% of the patients, 12% had vitiligo, 6% had celiac disease, 6% had juvenile idiopathic arthritis, 6% had Familial Mediterranean Fever, and one patient had both type-1diabetes mellitus and Hashimoto thyroiditis (HT). The subjects with CAIDs were females (6 patients) with insidious type of presentation. Autoimmune diseases were observed in 24% of the parents (3 had HT, 2 had vitiligo).
Conclusion: AIH is a rare but important cause of chronic liver disease in children. Frequent association with autoimmune diseases should be kept in mind as the clinical expression of the associated disease can be extremely variable therefore diagnosis and treatment delay may occur.

Anahtar Kelimeler

Autoimmune hepatitis, children,, concomitant autoimmune diseases

Destekleyen Kurum

yok

Proje Numarası

yok

Teşekkür

Dear publication Office, Thank you for the time and effort you spent on manuscript entitled “MODE OF PRESENTATION AND ASSOCIATED AUTOIMMUNE DISEASES IN CHILDREN WITH AUTOIMMUNE HEPATITIS'' Sincerely, Nelgin Gerenli Pediatric gastroenterology and hepatology department University of Health Sciences, Umraniye Research and Training Hospital

OTOİMMÜN HEPATİT TANILI ÇOCUKLARDA BAŞVURU ŞEKLİ VE EŞLİK EDEN OTOİMMÜN HASTALIK VARLIĞI

Öz

Giriş ve Amaç: Otoimmün hepatit (OİH)çocukluk çağında nadir görülen karaciğerin inflamatuar hastalığıdır. Klinik prezantasyon çok değişkendir. OİH olan hastaların yaklaşık %20-40’nda eşlik eden otoimmün hastalıklar gözlenebilir. Bu çalışmamızda OİH tanısı almış çocukların başvuru şekli, biyokimyasal parametreleri, eşlik eden otoimmün veya otoinflamatuar hastalık varlığının araştırılması amaçlanmıştır.
Gereç ve Yöntem: Yaşları 6 ila 18 arasında değişen, OİH tanısı almış 17 değerlendirildi. Başvuru şekli, laboratuvar bulguları, eşlik eden otoimmün veya otoinflamatuar hastalıklar, anne-babada otoimmün hastalık varlığı kayıt edildi. Biyokimyasal parametreler başvuru şekline ve eşlik eden otoimmün hastalık varlığına göre kıyaslandı.
Bulgular: OİH olan çocukların ondördü ( 10 kız, 4 erkek) tip1 OİH, üçü (1 kız, 2 erkek) ise tip-2OİH tanısı almıştı. Hastaların %53 akut hepatit, % 47 ise insidental karaciğer enzim yüksekliği nedeniyle başvurmuştu. OİH olan çocukların %35’inde eşlik eden bir veya birden fazla otoimmün veya otoinflamatuar hastalık gözlendi. En sık vitiligo (%12), ikinci sıklıkta ise Çölyak hastalığı (% 6) juvenil idiopatik artrit (%6), Ailevi Akdeniz ateşi %6 oranında gözlendi. Tip-1 OİH nedeniyle takip edilen bir hastada hem tip 1 diabetes mellitus hem de Hashimoto tiroiditi (HT) vardı. Eşlik eden otoimmün hastalığı olan çocukların hepsinin cinsiyeti kız ve insidental olarak enzim yüksekliği nedeniyle başvurmuş olanlardı. Hasta ebeveynlerinin % 24 de otiommün hastalık (üç kişide HT, iki kişide vitiligo) vardı.
Sonuç: Çocuklarda OİH, kronik karaciğer hastalığının nadir fakat önemli nedenleri arasındadır. OİH ile birlikte diğer otoimmün ve otoinflamatuar hastalıkların da eşlik edebileceği, erken tanının tedavinin gecikmemesi açısından önemli olduğu unutulmamalıdır.

Anahtar Kelimeler

OTOİMMÜN HEPATİT,, ÇOCUK, EŞLİK EDEN OTOİMMÜN HASTALIK

Proje Numarası

yok

Kaynakça

• References 1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015 Oct;63(4):971-1004. 2. Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 Apr 12;4:18017.
• 3. Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008;43(10):1232–40.
• 4. Sokollik C, McLin VA, Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. Juvenile autoimmune hepatitis: A comprehensive review. J Autoimmun. 2018 Dec;95:69-76.
• 5. Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722.
• 6. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis. 2009 Aug;29(3):297-306.
• 7. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20 years experience. Hepatology. 1997;25:541-7.
• 8. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001 Mar;33(3):544-53
• 9. Floreani A, Liberal R, Vergani D, Mieli-Vergani G. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun. 2013 Oct;46:7-16.
• 10. Volk M, Reau N. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: A Patient-Friendly Summary of the 2019 AASLD Guidelines. Clin Liver Dis (Hoboken). 2021 Feb 28;17(2):85-89.
• 11. Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015 Jan 7;21(1):60-83. 12. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004 Oct 15;1(1):2.
• 13. Nakaji M, Hayashi Y, Ninomiya T, et al. Histological grading and staging in chronic hepatitis: its practical correlation. Pathol Int. 2002 Nov;52(11):683-90.
• 14. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22: 696–699.
• 15. Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):345-360. 16. Rodrigues AT, Liu PM, Fagundes ED, et al. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome. J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):76-81.
• 17. Teufel A, Weinmann A, Kahaly GJ, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010 Mar;44(3):208-13. 18. Wong GW, Heneghan MA. Association of Extrahepatic Manifestations with Autoimmune Hepatitis. Dig Dis. 2015;33 Suppl 2:25-35.
• 19. Van Gerven NM, Verwer BJ, Witte BI, et al. Dutch Autoimmune hepatitis STUDY group: Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol 2014;49:1245–1254.
• 20. Clemente MG, De Virgiliis S. Autoantigen characterization in liver/kidney microsome positive hepatitis. Dig Liver Dis. 2000 Jan-Feb;32(1):39-45.
• 21. Pando M, Larriba J, Fernandez GC, et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology. 1999 Dec;30(6):1374-80.
• 22. Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005 Jul;42(1):53-62.
• 23. Yassin S, De Lacy R, Pillay K, Goddard E. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa. J Trop Pediatr. 2020 Aug 1;66(4):448-457.
• 24. Fallatah HI, Akbar HO, Qari YA. Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia. Saudi J Gastroenterol. 2010 Apr-Jun;16(2):95-9.
• 25. Farid E, Isa HM, Al Nasef M, Mohamed R, Jamsheer H. Childhood Autoimmune Hepatitis in Bahrain: a Tertiary Center Experience. Iran J Immunol. 2015 Jun;12(2):141-8. 26. O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology. 2008 Aug;48(2):550-6.
• 27. Low AS, Tan M, Garcia A, Aw M, Quak SH. Childhood autoimmune hepatitis in a paediatric unit of a tertiary care hospital. Singapore Med J. 2014 Dec;55(12):648-51.
• 28. Sucher E, Sucher R, Gradistanac T, et al. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res. 2019 Nov 25;2019:9437043.
• 29. Harrison L, Gleeson D. Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)? Liver Int. 2019 Apr;39(4):610-620.
• 30. Guo L, Zhou L, Zhang N, Deng B, Wang B. Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterol Res Pract. 2017;2017:2376231.